Want to track STX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Shield Therapeutics PLC (STX) Statistics
Valuation metrics
Market Cap -
Enterprise value 107.71M
Trailing P/E (ttm) -4.79
Forward P/E -
PEG ratio -0.05
Price/Sales (ttm) 1.75
Price/Book (mrq) -5.88
Enterprise Value/Revenue 2.11
Enterprise Value/EBITDA -11.76
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 762.99K
Average volume (90 days) 1.9M
Price summary
52-Week low 0
52-Week high 0
Beta -
50-Day moving average 6.18
200-Day moving average 8.42
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 7 Jul 2026
Ex-Dividend Date 24 Jun 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.36%
Operating margin -0.2%
Operational effectiveness
Return on assets -0.28%
Return on equity 1.22%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.01
Total debt (mrq) -
Total Debt/Equity (mrq) -2
Current ratio (mrq) 0.9%
Book value per share (mrq) -0.01
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
